Cartesian Therapeutics, Inc.
RNAC
$6.65
-$0.06-0.89%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -326.00% | 189.70% | -72.73% | 57.60% | -274.78% |
| Total Depreciation and Amortization | 2.89% | -49.05% | 137.86% | 69.93% | 45.92% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 158.99% | -6,253.03% | 112.93% | -134.65% | 227.19% |
| Change in Net Operating Assets | 135.15% | 78.71% | -203.43% | -73.47% | 180.46% |
| Cash from Operations | 10.96% | 24.18% | -230.02% | -151.14% | 194.77% |
| Capital Expenditure | 50.21% | -141.40% | -52.48% | 88.63% | -290.61% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 50.21% | -141.40% | -203.67% | 94.29% | -290.61% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -94.12% | -53.55% | -78.45% | -99.32% | 103,645.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -72.00% | 99.70% | -12,336.36% | -- | -- |
| Cash from Financing | -163.33% | 100.75% | -1,124.90% | -99.37% | 103,645.00% |
| Foreign Exchange rate Adjustments | -183.33% | -62.50% | 313.33% | 0.00% | -207.14% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 15.49% | 37.71% | -388.40% | -104.99% | 930.06% |